leisure time -WSS

leisure time

author：leisure time 2025-09-07 14:03:03 - browse：988

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Tesla recalling nearly 16,000 of its 2021

focus

WSS

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Reanimated hearts work just as well for transplants, study finds

Can medical device makers keep up in the race to treat obesity?

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Stanford president faces new allegations over 1999 paper

Mom launches Girl Scout troop for LGBTQ youth in Texas

entertainment

leisure time

focus

23andMe had bad news about my health. I wish a person had delivered it

Senate panel passes drug pricing bills, but drops one PBM reform

Medicare details structure of new drug price negotiation program

Affordable Connectivity Program vital to health care, experts say

Medical records are filled with copy

Tesla recalling nearly 16,000 of its 2021

How one medical school became remarkably diverse

Eli Lilly’s Mounjaro succeeds in second weight

Medical leaders decry Supreme Court decision on affirmative action

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

entertainment

Tesla recalling nearly 16,000 of its 2021

Driven by the pandemic, applicants flood public health schools

Stanford president's case begs question: Who takes blame?

DeSantis talks Trump, trans issues and 'what wokeness is'

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

focus

focus

focus

explore